RNS Number : 5723E
Bowleven plc
09 November 2020
9 November 2020
Bowleven plc ('Bowleven')
Block Admission Six Monthly Return
This Block Admission Six Monthly Return is intended to comply with the requirements of AIM Rule 29 and Schedule Six.
|
Name of company:
|
BOWLEVEN PLC
|
|
Name of scheme:
|
1) BOWLEVEN PLC APPROVED CSOP SCHEME (WITH UNAPPROVED SCHEDULE)
2) BOWLEVEN PLC SCHEDULE 4 CSOP SCHEME (WITH UNAPPROVED SCHEDULE)
|
|
Period of return:
|
From:
|
9 MAY 2020
|
To:
|
8 NOVEMBER 2020
|
|
Balance of unallotted securities under scheme(s) from previous return:
|
659,526
|
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
|
NIL
|
|
Less: Number of securities issued/allotted under scheme(s) during period:
|
NIL
|
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
|
659,526
|
|
Number and class of share(s) (amount of stock/debit securities) originally admitted and the Date of Admission:
|
852,105 ORDINARY SHARES
9 MAY 2018
|
|
Total number of shares in issue at the end of the period:
|
335,272,933
|
| |
|
|
|
|
ENQUIRIES
For further information, please contact:
|
Bowleven plc
|
|
|
Eli Chahin, Chief Executive
|
00 44 20 3327 0150
|
|
|
|
|
Celicourt Communications Ltd
|
|
|
Mark Antelme
|
00 44 20 8434 2643
|
|
Jimmy Lea
|
|
|
|
|
|
Shore Capital Ltd (NOMAD and Broker)
|
|
|
Antonio Bossi
|
00 44 207 408 4090
|
|
Robert Finlay
|
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END
BLRBLBDBRXGDGGL
|
